The iM-DrawdownShield model for SPY remains in 'Hold' despite the S&P 500's sharp November 5 drop, with the next sell ...

Why Vista Energy is a Buy: low valuation, strong free cash flow at $65 Brent, production growth, buybacks, and pipeline ...

Green Thumb Industries posted record Q3-2026 revenue and sees 2027 synergies, but election and cannabis sector volatility ...

ASC's strong valuation metrics and high recent cash generation are offset by the sector's notorious cyclicality. Geopolitical ...

Bloom Energy looks like a speculative buy after a 30% drop, with data center power demand creating major upside potential.

Global EV sales shift as Europe surges, China slows, and US lags.

Discover a technical analysis biotech strategy targeting post-Phase 2 small caps with strong momentum and pipeline progress.

In the near term, we expect the market to do what it often does when working its way through a sea of unknown outcomes - and ...

In S&P Global 100, U.S.-domiciled companies represented 80.7% of index weight as of Sept. 30, 2026, yet 53.9% of estimated ...

CECO Environmental offers a compelling entry point after a pullback, with record orders, strong backlog, margin expansion, ...

AbbVie sees potential Botox and filler demand from GLP-1 users as small studies show improved facial satisfaction after ...

Novo Nordisk says Wegovy improved liver health in MASH patients with BMI under 27, hinting at broader use beyond obesity.